Published in Cancer Weekly, August 31st, 2004
According to recent research published in the journal Urological Research, "the aim of the study was to quantify the expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) in prostate cancer and adjacent non-tumorous tissue in a standardized experimental set-up and to evaluate the paracrine effects of three endothelial stimuli on neovascularization."
"Immunohistochemical staining of prostate cancer (PCa) specimens for VEGF, bFGF, FGF and the endothelial marker CD31 was performed (n=56). Sections...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.